-
-
-
-
-
-
-
Sesen Bio Reports Third Quarter 2021 Financial Results and Business Update
-
-
-
-
-
-
-
Sesen Bio (SESN) Reports Q1 Loss of $0.35/sh
-
-
-
-
-
-
-
Sesen Bio Reports Second Quarter 2020 Financial Results and Business Update
-
-
-
-
-
-
-
Sesen Bio Reports Positive, Preliminary Data Update from Phase 3 VISTA Trial for High-Risk Non-Muscle Invasive Bladder Cancer
-
-
-
-
-
-
-
Sesen Bio Reports Second Quarter 2018 Financial Results and Pipeline Updates
976,640 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All